NCT06700616 2026-03-16
MG Cohort
AstraZeneca
Active not recruiting
Clinical Trials
10 trialsNCT07472777 2026-03-16
Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis
Beijing University of Chinese Medicine
Completed
NCT06909253 2026-03-13
MG-ARCADIA
AstraZeneca
Recruiting
NCT07247279 2026-03-13
Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
AstraZeneca
Recruiting
NCT06718855 2026-02-19
MYCOG
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Completed
NCT04202341 2026-02-18
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Alexion Pharmaceuticals, Inc.
Recruiting
NCT07294170 2026-02-18
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
argenx
Recruiting
NCT06298565 2026-02-17
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
argenx
Recruiting
NCT06299748 2026-02-17
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
argenx
Recruiting
NCT07411963 2026-02-17
EARLY-MG
Centre Hospitalier Universitaire de Nice
Recruiting